# A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

> **NCT00647491** · PHASE2,PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 352 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** adalimumab
- **BIOLOGICAL:** adalimumab
- **BIOLOGICAL:** adalimumab
- **BIOLOGICAL:** placebo

## Key facts

- **NCT ID:** NCT00647491
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2005-06
- **Final completion:** 2005-08
- **Target enrollment:** 352 (ACTUAL)
- **Last updated:** 2008-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00647491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00647491, "A Study of Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00647491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*